A highlight reel featuring Exact Sciences’ title sponsorship of this premier PGA TOUR Champions tournament.
Cologuard analyzes both DNA alterations and blood in the stool to detect the presence of colon cancer and precancers. With Cologuard, patients can provide a sample in the privacy of their own home.
Cologuard is the first FDA-approved, noninvasive, stool-based DNA (sDNA) colorectal cancer screening test. Cologuard is intended for men and women 50 years or older at average risk for colorectal cancer.
Cologuard logo image.
Oncotype DX logo image
Exact Sciences and Genomic Health have teamed up to take cancer on, together. By combining our leading portfolio of products, we are continuing our relentless pursuit of earlier detection and smarter answers.